Parenteral Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 67.23 million compared to INR 95.98 million a year ago. Revenue was INR 67.56 million compared to INR 96.35 million a year ago. Net loss was INR 1,001.75 million compared to INR 968.68 million a year ago. Basic loss per share from continuing operations was INR 33.59 compared to INR 32.55 a year ago. Diluted loss per share from continuing operations was INR 33.59 compared to INR 32.55 a year ago. Basic loss per share was INR 33.59 compared to INR 32.55 a year ago. Diluted loss per share was INR 33.59 compared to INR 32.55 a year ago.